The KEAP1–NRF2 System as a Molecular Target of Cancer Treatment
Open accessThe DOI matches its Crossref record; 114 of the 115 references it cites were found in a registry or an index.
Abstract
The Kelch-like ECH-associated protein 1 (KEAP1)—Nuclear factor erythroid-derived 2-like 2 (encoded by the Nfe2l2 gene; NRF2) system attracts extensive interest from scientists in basic and clinical cancer research fields, as NRF2 exhibits activity as both an oncogene and tumor suppressor, depending on the context. Especially unique and malignant, NRF2-addicted cancers exhibit high levels of NRF2 expression. Somatic mutations identified in the NRF2 or KEAP1 genes of NRF2-addicted cancers cause the stabilization and accumulation of NRF2. NRF2-addicted cancers hijack the intrinsic roles that NRF2 plays in cytoprotection, including antioxidative and anti-electrophilic responses, as well as metabolic reprogramming, and acquire a marked advantage to survive under severe and limited microenvironments. Therefore, NRF2 inhibitors are expected to have therapeutic effects in patients with NRF2-addicted cancers. In contrast, NRF2 activation in host immune cells exerts significant suppression of cancer cell growth, indicating that NRF2 inducers also have the potential to be therapeutics for cancers. Thus, the KEAP1–NRF2 system makes a broad range of contributions to both cancer development and suppression. These observations thus demonstrate that both NRF2 inhibitors and inducers are useful for the treatment of cancers with high NRF2 activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999 · cited 1×
“Of the NRF2 target genes, Nqo1 encodes a representative marker enzyme that has been exploited for the evaluation of NRF2 activity [11].”
BackgroundItoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634 · cited 4×
“As an approach to delineate the domain function, a yeast two-hybrid screen was conducted using the Neh2 domain as bait, and we identified a new molecule, KEAP1 [20].”
BackgroundMethodInfluentialSelf-citationCell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630 · cited 1×
“our body is equipped with the ability to eliminate these toxic xenobiotics and adapt to the environment, which we refer to as the adaptive response or the environmental stress response [3,4].”
BackgroundNegative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551 · cited 6×
“In contrast, Pten (phosphatase and tensin homolog deleted on chromosome 10) dephosphorylates PIP3 to PIP2 and thus counteracts the action of PI3K [26]. v-akt murine thymoma viral oncogene homolog (protein kinase B; Akt) is activated via phosphorylation.”
BackgroundInfluentialTracking the Evolution of Non–Small-Cell Lung Cancer
Jamal-Hanjani, M., Wilson, G. A., McGranahan, N., Birkbak, N. J., Watkins, T. B. K., Veeriah, S., Shafi, S., Johnson, D. H., Mitter, R., Rosenthal, R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1616288 · Cited by 2,349 · cited 1×
“Aberrant activation of NRF2 has been shown to provoke malignant growth and anticancer drug resistance in many types of cancers [53] (see Section 6).”
BackgroundKomatsu, M., Kurokawa, H., Waguri, S., Taguchi, K., Kobayashi, A., Ichimura, Y., Sou, Y.-S., Ueno, I., Sakamoto, A., Tong, K. I., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2021 · Cited by 2,288 · cited 1×
“As p62 is a scaffold or chaperone protein in autophagy [36], the most plausible scenario is that p62 binds to KEAP1 and brings KEAP1 to the autophagosome.”
BackgroundSelf-citationOncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
DeNicola, G. M., Karreth, F. A., Humpton, T. J., Gopinathan, A., Wei, C., Frese, K., Mangal, D., Yu, K. H., Yeo, C. J., Calhoun, E. S., et al. (2011) · Nature · doi:10.1038/nature10189 · Cited by 2,277 · cited 1×
“Furthermore, NRF2 gene expression is transcriptionally regulated by oncogenes, such as K-Ras and c-Myc [75].”
BackgroundKobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224 · cited 2×
“NRF2 has a very short half-life, which is less than 20 min [9,10].”
BackgroundThe KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis
Yamamoto, M., Kensler, T. W., & Motohashi, H. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2017 · Cited by 1,968 · cited 1×
“Nuclear factor erythroid-derived 2-like 2; encoded by the Nfe2l2 gene (NRF2) is a transcription factor that controls the environmental stress response by changing gene expression profiles [5].”
BackgroundSelf-citationAnalysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,898 · cited 1×
“To verify this notion, we exploited the KrasG12Ddriven lung adenocarcinoma system [96] and examined two mouse models with different NRF2 activity levels in the presence of adenovirus expressing Cre recombinase [97]: KEAP1flox-A mice [17] and KEAP1flox-B mice [98].”
MethodNrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
Kobayashi, E. H., Suzuki, T., Funayama, R., Nagashima, T., Hayashi, M., Sekine, H., Tanaka, N., Moriguchi, T., Motohashi, H., Nakayama, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms11624 · Cited by 1,878 · cited 2×
“In contrast, NRF2 downregulates genes encoding proinflammatory factors such as interleukin-6 (IL6) and interleukin 1β (IL1β) [15].”
BackgroundSelf-citationMoi, P., Chan, K., Asunis, I., Cao, A., & Kan, Y. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9926 · Cited by 1,607 · cited 1×
“After the discovery of NRF2 [18,19], its Neh2 domain was soon identified as essential for high-level NRF2 activity in a chicken erythroid cell line [20].”
BackgroundMolecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution
Taguchi, K., Motohashi, H., & Yamamoto, M. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01473.x · Cited by 1,478
Self-citationGuichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Maad, I. B., Calderaro, J., Bioulac-Sage, P., Letexier, M., Degos, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2256 · Cited by 1,453
Phosphorylation of p62 Activates the Keap1-Nrf2 Pathway during Selective Autophagy
Ichimura, Y., Waguri, S., Sou, Y.-S., Kageyama, S., Hasegawa, J., Ishimura, R., Saito, T., Yang, Y., Kouno, T., Fukutomi, T., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.003 · Cited by 1,205 · cited 1×
“, pSTGE) increases the binding affinity as the pSTGE motif mimics the ETGE motif in NRF2 [37].”
BackgroundSelf-citationLinker, R. A., Lee, D.-H., Ryan, S., van Dam, A. M., Conrad, R., Bista, P., Zeng, W., Hronowsky, X., Buko, A., Chollate, S., et al. (2011) · Brain · doi:10.1093/brain/awq386 · Cited by 1,155 · cited 1×
“DMF also leads to enhanced immunomodulatory and antioxidant actions, leading to neuroprotection [67].”
BackgroundThe exposome and health: Where chemistry meets biology
Vermeulen, R., Schymanski, E. L., Barabási, A.-L., & Miller, G. W. (2020) · Science · doi:10.1126/science.aay3164 · Cited by 1,065 · cited 1×
“Our body is constantly exposed to a variety of chemical stresses from external environments, including natural ultraviolet radiation, air pollutants from urban industries and water pollutants from micro/nanoplastic particles [1].”
BackgroundDysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer
Singh, A., Misra, V., Thimmulappa, R. K., Lee, H., Ames, S., Hoque, M. O., Herman, J. G., Baylin, S. B., Sidransky, D., Gabrielson, E., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030420 · Cited by 1,060 · cited 4×
“The discoveries of somatic mutations in the KEAP1 and NRF2 genes [55,69] and NRF2-addicted cancers [54] established other lines of important cancer-related studies related to the KEAP1–NRF2 system; therefore, this system has become very popular in cancer science.”
BackgroundInfluentialMinutes: Mutants of Drosophila autonomously affecting cell division rate
Morata, G., & Ripoll, P. (1975) · Developmental Biology · doi:10.1016/0012-1606(75)90330-9 · Cited by 979
Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation
Wakabayashi, N., Itoh, K., Wakabayashi, J., Motohashi, H., Noda, S., Takahashi, S., Imakado, S., Kotsuji, T., Otsuka, F., Roop, D. R., et al. (2003) · Nature Genetics · doi:10.1038/ng1248 · Cited by 883 · cited 2×
“Simultaneous NRF2 deletion attenuates the phenotype, unequivocally demonstrating that aberrant NRF2 activation provokes hyper-keratinization in KEAP1-knockout mice [24].”
BackgroundSelf-citationItoh, K., Tong, K. I., & Yamamoto, M. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.02.075 · Cited by 864 · cited 1×
“our body is equipped with the ability to eliminate these toxic xenobiotics and adapt to the environment, which we refer to as the adaptive response or the environmental stress response [3,4].”
BackgroundSelf-citationItoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., O'Connor, T., & Yamamoto, M. (2003) · Genes to Cells · doi:10.1046/j.1365-2443.2003.00640.x · Cited by 816 · cited 1×
“NRF2 has a very short half-life, which is less than 20 min [9,10].”
BackgroundSelf-citationRada, P., Rojo, A. I., Chowdhry, S., McMahon, M., Hayes, J. D., & Cuadrado, A. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01204-10 · Cited by 759 · cited 1×
“These residues are located in the Neh6 domain of NRF2 [27,28].”
BackgroundTong, K. I., Katoh, Y., Kusunoki, H., Itoh, K., Tanaka, T., & Yamamoto, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.2887-2900.2006 · Cited by 759
Self-citationStructural basis for defects of Keap1 activity provoked by its point mutations in lung cancer
Padmanabhan, B., Tong, K. I., Ohta, T., Nakamura, Y., Scharlock, M., Ohtsuji, M., Kang, M.-I., Kobayashi, A., Yokoyama, S., & Yamamoto, M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.013 · Cited by 735 · cited 2×
“The discoveries of somatic mutations in the KEAP1 and NRF2 genes [55,69] and NRF2-addicted cancers [54] established other lines of important cancer-related studies related to the KEAP1–NRF2 system; therefore, this system has become very popular in cancer science.”
BackgroundSelf-citationSKN-1 links C. elegans mesendodermal specification to a conserved oxidative stress response
An, J. H., & Blackwell, T. K. (2003) · Genes & Development · doi:10.1101/gad.1107803 · Cited by 726 · cited 1×
“Mammalian NRF2 is an ortholog of Caenorhabditis elegans SKN-1 (Skinhead-1) [29].”
BackgroundHepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
Horie, Y., Suzuki, A., Kataoka, E., Sasaki, T., Hamada, K., Sasaki, J., Mizuno, K., Hasegawa, G., Kishimoto, H., Iizuka, M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420513 · Cited by 698 · cited 1×
“Liver-specific Pten-knockout mice (Ptenflox/flox: Albumin-Cre; Pten-Alb mice) are liver disease models used to develop steatosis, nonalcoholic steatohepatitis (NASH) and liver cancers stepwise [87].”
BackgroundBrusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
Ren, D., Villeneuve, N. F., Jiang, T., Wu, T., Lau, A., Toppin, H. A., & Zhang, D. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014275108 · Cited by 673 · cited 1×
“It has been reported that brusatol enhances the efficacy of chemotherapy by inhibiting NRF2 [80] (Figure 4A).”
BackgroundPersistent activation of Nrf2 through p62 in hepatocellular carcinoma cells
Inami, Y., Waguri, S., Sakamoto, A., Kouno, T., Nakada, K., Hino, O., Watanabe, S., Ando, J., Iwadate, M., Yamamoto, M., et al. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201102031 · Cited by 604 · cited 1×
“In hepatitis and cirrhosis, which are pre-HCC diseases, simultaneous accumulation of P62 and KEAP1 does not frequently occur [86].”
BackgroundSelf-citationAdam, J., Hatipoglu, E., O'Flaherty, L., Ternette, N., Sahgal, N., Lockstone, H., Baban, D., Nye, E., Stamp, G. W., Wolhuter, K., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.006 · Cited by 585 · cited 1×
“In addition to these mutations, oncometabolites [70,71], exon skipping [72], and promoter methylation [73] lead to constitutive NRF2 activation in cancers [14,74].”
BackgroundDinkova-Kostova, A. T., Liby, K. T., Stephenson, K. K., Holtzclaw, W. D., Gao, X., Suh, N., Williams, C., Risingsong, R., Honda, T., Gribble, G. W., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500815102 · Cited by 569
Cancer Chemoprevention Mechanisms Mediated Through the Keap1–Nrf2 Pathway
Hayes, J. D., McMahon, M., Chowdhry, S., & Dinkova-Kostova, A. T. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3221 · Cited by 539
Solt, D. B., Medline, A., & Farber, E. (1977) · PubMed · Cited by 535
The KEAP1–NRF2 System in Cancer
Taguchi, K., & Yamamoto, M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00085 · Cited by 527 · cited 4×
“The discoveries of somatic mutations in the KEAP1 and NRF2 genes [55,69] and NRF2-addicted cancers [54] established other lines of important cancer-related studies related to the KEAP1–NRF2 system; therefore, this system has become very popular in cancer science.”
BackgroundInfluentialSelf-citationKeap1 degradation by autophagy for the maintenance of redox homeostasis
Taguchi, K., Fujikawa, N., Komatsu, M., Ishii, T., Unno, M., Akaike, T., Motohashi, H., & Yamamoto, M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121572109 · Cited by 482 · cited 3×
“Importantly, the proteasome inhibitor MG132 was reproducibly ineffective at the KEAP1 protein level [34,35], indicating that the 26S proteasome is not critical for KEAP1 degradation.”
BackgroundSelf-citationRada, P., Rojo, A. I., Evrard-Todeschi, N., Innamorato, N. G., Cotte, A., Jaworski, T., Tobón-Velasco, J. C., Devijver, H., García-Mayoral, M. F., Van Leuven, F., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00180-12 · Cited by 474
Two-site substrate recognition model for the Keap1-Nrf2 system: A hinge and latch mechanism
Tong, K. I., Kobayashi, A., Katsuoka, F., & Yamamoto, M. (2006) · Biological Chemistry · doi:10.1515/bc.2006.164 · Cited by 473 · cited 1×
“This difference in the binding affinity of KEAP1 and DLGex as well as ETGE motifs led to the proposal of the hinge–latch model [22].”
BackgroundSelf-citationMoreno, E., Basler, K., & Morata, G. (2002) · Nature · doi:10.1038/416755a · Cited by 451
Sulforaphane treatment of autism spectrum disorder (ASD)
Singh, K., Connors, S. L., Macklin, E. A., Smith, K. D., Fahey, J. W., Talalay, P., & Zimmerman, A. W. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416940111 · Cited by 449 · cited 1×
“It has been reported that sulforaphane alleviates abnormal cognition and behavior in people with autism spectrum disorder [65].”
BackgroundItoh, K., Igarashi, K., Hayashi, N., Nishizawa, M., & Yamamoto, M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4184 · Cited by 441 · cited 1×
“After the discovery of NRF2 [18,19], its Neh2 domain was soon identified as essential for high-level NRF2 activity in a chicken erythroid cell line [20].”
BackgroundSelf-citationMcMahon, M., Thomas, N., Itoh, K., Yamamoto, M., & Hayes, J. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403061200 · Cited by 404 · cited 2×
“elegans SKN-1 and in mice, rats and humans NRF2 [33].”
BackgroundSelf-citationOoi, A., Wong, J.-C., Petillo, D., Roossien, D., Perrier-Trudova, V., Whitten, D., Min, B. W. H., Tan, M.-H., Zhang, Z., Yang, X. J., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.08.024 · Cited by 401 · cited 1×
“In addition to these mutations, oncometabolites [70,71], exon skipping [72], and promoter methylation [73] lead to constitutive NRF2 activation in cancers [14,74].”
BackgroundSuzuki, T., & Yamamoto, M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.800169 · Cited by 400 · cited 3×
“NRF2 is activated when cells are exposed to oxidative stresses or toxic chemicals (many of which are electrophilic) [7,8].”
BackgroundSelf-citationThe Keap1–Nrf2 system in cancers: stress response and anabolic metabolism
Mitsuishi, Y., Motohashi, H., & Yamamoto, M. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00200 · Cited by 392
Self-citationSaito, T., Ichimura, Y., Taguchi, K., Suzuki, T., Mizushima, T., Takagi, K., Hirose, Y., Nagahashi, M., Iso, T., Fukutomi, T., et al. (2016) · Nature Communications · doi:10.1038/ncomms12030 · Cited by 362 · cited 15×
“Constitutive NRF2 activation by somatic mutations in the NRF2 gene coincides well with the overexpression of NRF2-target gene products, including GSTP, in preneoplastic foci and HCCs.”
BackgroundInfluentialSelf-citationKeap1–Nrf2 Signaling: A Target for Cancer Prevention by Sulforaphane
Kensler, T. W., Egner, P. A., Agyeman, A. S., Visvanathan, K., Groopman, J. D., Chen, J.-G., Chen, T.-Y., Fahey, J. W., & Talalay, P. (2012) · Topics in Current Chemistry · doi:10.1007/128_2012_339 · Cited by 361 · cited 2×
“The KEAP1–NRF2 system has been intensively studied in the context of cancer chemoprevention, which revealed that the system activates antioxidant and detoxicating enzymes and protects our bodies from chemical carcinogens [100].”
BackgroundMarzec, J. M., Christie, J. D., Reddy, S. P., Jedlicka, A. E., Vuong, H., Lanken, P. N., Aplenc, R., Yamamoto, T., Yamamoto, M., Cho, H.-Y., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-7759com · Cited by 340 · cited 2×
“Decreased expression of NRF2 in A/A homozygotes has been shown to be correlated with increased risk of acute lung injury [45] and lung cancer incidence, especially in patients who have ever smoked [49].”
BackgroundSelf-citationZhang, D. D., Lo, S.-C., Sun, Z., Habib, G. M., Lieberman, M. W., & Hannink, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501279200 · Cited by 298 · cited 3×
“Importantly, the proteasome inhibitor MG132 was reproducibly ineffective at the KEAP1 protein level [34,35], indicating that the 26S proteasome is not critical for KEAP1 degradation.”
BackgroundMolecular Mechanism of Cellular Oxidative Stress Sensing by Keap1
Suzuki, T., Muramatsu, A., Saito, R., Iso, T., Shibata, T., Kuwata, K., Kawaguchi, S.-I., Iwawaki, T., Adachi, S., Suda, H., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.047 · Cited by 287 · cited 4×
“Indeed, elaborate analyses have clarified that hydrogen peroxide (Class IV inducer) interacts with Cys226/613/622/624 in KEAP1 [7].”
BackgroundInfluentialSelf-citationp62/SQSTM1 – steering the cell through health and disease
Sánchez-Martín, P., & Komatsu, M. (2018) · Journal of Cell Science · doi:10.1242/jcs.222836 · Cited by 282 · cited 1×
“Although in a manner different from that of the aforementioned observations, it has been reported that p62 is ubiquitinated by KEAP1 at Lys420 in the ubiquitin-associated (UBA) domain [43], resulting in its degradation by autophagy [44].”
BackgroundFukutomi, T., Takagi, K., Mizushima, T., Ohuchi, N., & Yamamoto, M. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01191-13 · Cited by 260
Self-citationHypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues
Wang, R., An, J., Ji, F., Jiao, H., Sun, H., & Zhou, D. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.004 · Cited by 259 · cited 1×
“In addition to these mutations, oncometabolites [70,71], exon skipping [72], and promoter methylation [73] lead to constitutive NRF2 activation in cancers [14,74].”
BackgroundJiang, Z.-Y., Lu, M.-C., Xu, L., Yang, T.-T., Xi, M.-Y., Xu, X.-L., Guo, X.-K., Zhang, X.-J., You, Q.-D., & Sun, H.-P. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5000529 · Cited by 252 · cited 1×
“Improved compounds with naphthalene-based structures have been reported [93].”
BackgroundMarcotte, D., Zeng, W., Hus, J.-C., McKenzie, A., Hession, C., Jin, P., Bergeron, C., Lugovskoy, A., Enyedy, I., Cuervo, H., et al. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.04.019 · Cited by 239 · cited 1×
“The first identified KEAP1–NRF2 PPI chemical inhibitor was Cpd16 [N,N’-1,4naphthalenediylbis(4-methoxybenzenesulfonamide)], which is a naphthalene-based compound that interacts with the specific pocket within the KEAP1 DGR domain (Figure 5C) [92].”
BackgroundHong, D. S., Kurzrock, R., Supko, J. G., He, X., Naing, A., Wheler, J., Lawrence, D., Eder, J. P., Meyer, C. J., Ferguson, D. A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2703 · Cited by 236 · cited 1×
“A phase I first-in-human trial of CDDO-Me enrolled patients with advanced solid tumors and lymphomas [60].”
BackgroundOlayanju, A., Copple, I. M., Bryan, H. K., Edge, G. T., Sison, R. L., Wong, M. W., Lai, Z.-Q., Lin, Z.-X., Dunn, K., Sanderson, C. M., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.11.003 · Cited by 232
Genetic Analysis of Cytoprotective Functions Supported by Graded Expression of Keap1
Taguchi, K., Maher, J. M., Suzuki, T., Kawatani, Y., Motohashi, H., & Yamamoto, M. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01591-09 · Cited by 225 · cited 4×
“regulation of NRF2 activity is fine-tuned according to the KEAP1 expression level [17].”
BackgroundMethodInfluentialSelf-citationEnhancing Nrf2 Pathway by Disruption of Keap1 in Myeloid Leukocytes Protects against Sepsis
Kong, X., Thimmulappa, R., Craciun, F., Harvey, C., Singh, A., Kombairaju, P., Reddy, S. P., Remick, D., & Biswal, S. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201102-0271oc · Cited by 222 · cited 1×
“To verify this notion, we exploited the KrasG12Ddriven lung adenocarcinoma system [96] and examined two mouse models with different NRF2 activity levels in the presence of adenovirus expressing Cre recombinase [97]: KEAP1flox-A mice [17] and KEAP1flox-B mice [98].”
MethodBRG1 Interacts with Nrf2 To Selectively Mediate HO-1 Induction in Response to Oxidative Stress
Zhang, J., Ohta, T., Maruyama, A., Hosoya, T., Nishikawa, K., Maher, J. M., Shibahara, S., Itoh, K., & Yamamoto, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00700-06 · Cited by 213 · cited 13×
“Electrophilic NRF2-inducers have been found to interact with specific cysteine residues of KEAP1 [8].”
BackgroundMethodInfluentialSelf-citationRecurrent Loss of NFE2L2 Exon 2 Is a Mechanism for Nrf2 Pathway Activation in Human Cancers
Goldstein, L. D., Lee, J., Gnad, F., Klijn, C., Schaub, A., Reeder, J., Daemen, A., Bakalarski, C. E., Holcomb, T., Shames, D. S., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.010 · Cited by 200 · cited 1×
“In addition to these mutations, oncometabolites [70,71], exon skipping [72], and promoter methylation [73] lead to constitutive NRF2 activation in cancers [14,74].”
BackgroundLo, S.-C., & Hannink, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606539200 · Cited by 199 · cited 1×
“For instance, the following proteins have been reported as candidates: mitochondrial serine/threonine protein phosphatase PGAM family member 5 (PGAM5) [38], NFκB kinase inhibitor IKKβ (inhibitor of nuclear factor-kappa B kinase subunit β, referred to as IKBKB) [39], BRCA2 partner PALB2 (partner and localizer of BRCA2)…”
BackgroundPALB2 Interacts with KEAP1 To Promote NRF2 Nuclear Accumulation and Function
Ma, J., Cai, H., Wu, T., Sobhian, B., Huo, Y., Alcivar, A., Mehta, M., Cheung, K. L., Ganesan, S., Kong, A.-N. T., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06271-11 · Cited by 192 · cited 1×
“For instance, the following proteins have been reported as candidates: mitochondrial serine/threonine protein phosphatase PGAM family member 5 (PGAM5) [38], NFκB kinase inhibitor IKKβ (inhibitor of nuclear factor-kappa B kinase subunit β, referred to as IKBKB) [39], BRCA2 partner PALB2 (partner and localizer of BRCA2)…”
BackgroundChoe, K. P., Przybysz, A. J., & Strange, K. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01811-08 · Cited by 188 · cited 1×
“SKN-1 is ubiquitinated by WDR23 (WD40-repeat protein-23), which forms a complex with DDB1 (damaged DNA-binding protein 1) and Cul4, and ubiquitinated SKN-1 is degraded by the proteasome [30].”
BackgroundFahey, J. W., Wehage, S. L., Holtzclaw, W. D., Kensler, T. W., Egner, P. A., Shapiro, T. A., & Talalay, P. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0538 · Cited by 183 · cited 1×
“Glucoraphanin is converted to sulforaphane by myrosinase, which is produced by the microflora of the gastrointestinal tract [63].”
BackgroundHalofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation
Tsuchida, K., Tsujita, T., Hayashi, M., Ojima, A., Keleku-Lukwete, N., Katsuoka, F., Otsuki, A., Kikuchi, H., Oshima, Y., Suzuki, M., et al. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.041 · Cited by 166
Self-citationKeap1/Cullin3 Modulates p62/SQSTM1 Activity via UBA Domain Ubiquitination
Lee, Y., Chou, T.-F., Pittman, S. K., Keith, A. L., Razani, B., & Weihl, C. C. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.030 · Cited by 154 · cited 1×
“Although in a manner different from that of the aforementioned observations, it has been reported that p62 is ubiquitinated by KEAP1 at Lys420 in the ubiquitin-associated (UBA) domain [43], resulting in its degradation by autophagy [44].”
BackgroundCell competition: the winners and losers of fitness selection
Bowling, S., Lawlor, K., & Rodríguez, T. A. (2019) · Development · doi:10.1242/dev.167486 · Cited by 148
Shishodia, S., Sethi, G., Konopleva, M., Andreeff, M., & Aggarwal, B. B. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2044 · Cited by 148
Brusatol overcomes chemoresistance through inhibition of protein translation
Harder, B., Tian, W., La Clair, J. J., Tan, A., Ooi, A., Chapman, E., & Zhang, D. D. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22609 · Cited by 136
The PTEN/NRF2 Axis Promotes Human Carcinogenesis
Rojo, A. I., Rada, P., Mendiola, M., Ortega-Molina, A., Wojdyla, K., Rogowska-Wrzesinska, A., Hardisson, D., Serrano, M., & Cuadrado, A. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.5843 · Cited by 135 · cited 3×
“In 80% of human PTEN-deficient endometrioid tumors, NRF2 is overexpressed in accordance with HO-1 upregulation [77].”
BackgroundSasaki, A., Nagatake, T., Egami, R., Gu, G., Takigawa, I., Ikeda, W., Nakatani, T., Kunisawa, J., & Fujita, Y. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.104 · Cited by 124
Regulatory Nexus of Synthesis and Degradation Deciphers Cellular Nrf2 Expression Levels
Suzuki, T., Shibata, T., Takaya, K., Shiraishi, K., Kohno, T., Kunitoh, H., Tsuta, K., Furuta, K., Goto, K., Hosoda, F., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00065-13 · Cited by 123 · cited 3×
“A regulatory SNP (rSNP), rs6721961, is located within an ARE motif 617 bp upstream from the transcription start site of the NRF2 gene [49].”
BackgroundSelf-citationChemotherapy of Chicken Coccidiosis
Ryley, J. F., & Betts, M. J. (1973) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60459-7 · Cited by 123 · cited 1×
“Halofuginone is a racemic halogenated febrifugine derivative that was artificially synthesized as a less toxic compound [84].”
BackgroundAhmad, R., Raina, D., Meyer, C., & Kufe, D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3036 · Cited by 120
Chronic activation of JNK JAK/STAT and oxidative stress signalling causes the loser cell status
Kucinski, I., Dinan, M., Kolahgar, G., & Piddini, E. (2017) · Nature Communications · doi:10.1038/s41467-017-00145-y · Cited by 120
Liu, H., Dinkova-Kostova, A. T., & Talalay, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808346105 · Cited by 120 · cited 1×
“Sulforaphane has cytoprotective and antiinflammatory activities dependent on NRF2 [64].”
BackgroundIdentification of aldo-keto reductases as NRF2-target marker genes in human cells
Jung, K.-A., Choi, B.-H., Nam, C.-W., Song, M., Kim, S.-T., Lee, J. Y., & Kwak, M.-K. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2012.12.026 · Cited by 113 · cited 1×
“For example, Aldo-keto reductase (AKR) 1C1, an NRF2 target gene, has been suggested to be a good marker for NRF2 activity in human peripheral blood cells [51].”
BackgroundWDR23 regulates NRF2 independently of KEAP1
Lo, J. Y., Spatola, B. N., & Curran, S. P. (2017) · PLOS Genetics · doi:10.1371/journal.pgen.1006762 · Cited by 111 · cited 2×
“It has been shown that WDR23 directly regulates NRF2 degradation in human cells [31] (Figure 1B, right), and the suppression of WDR23 leads to the upregulated expression of cytoprotective genes in mammalian cells, as is the case for C.”
BackgroundThe NRF 2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis
Hammer, A., Waschbisch, A., Kuhbandner, K., Bayas, A., Lee, D., Duscha, A., Haghikia, A., Gold, R., & Linker, R. A. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.553 · Cited by 100 · cited 1×
“DMF reduces cytokine production and immune cell migration by activating NRF2 [68].”
BackgroundNrf2 Enhances Cholangiocyte Expansion in Pten-Deficient Livers
Taguchi, K., Hirano, I., Itoh, T., Tanaka, M., Miyajima, A., Suzuki, A., Motohashi, H., & Yamamoto, M. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01384-13 · Cited by 98 · cited 3×
“However, in Pten-deleted livers of juvenile mice, GSK3β inactivation elicited by Akt activation disrupts the accumulation of substantial amounts of NRF2 in the nucleus [25], indicating that inactivation of the βTrCP–Cul1 pathway alone is not strong enough to cause NRF2 accumulation.”
BackgroundSelf-citationEnhancer remodeling promotes tumor-initiating activity in NRF2-activated non-small cell lung cancers
Okazaki, K., Anzawa, H., Liu, Z., Ota, N., Kitamura, H., Onodera, Y., Alam, M. M., Matsumaru, D., Suzuki, T., Katsuoka, F., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19593-0 · Cited by 94 · cited 1×
“Similarly, NOTCH3 (neurogenic locus notch homolog protein 3) was recently found to play an important role in carcinogenesis under the regulation of NRF2 [79].”
BackgroundSelf-citationNrf2, but not β‐catenin, mutation represents an early event in rat hepatocarcinogenesis
Zavattari, P., Perra, A., Menegon, S., Kowalik, M. A., Petrelli, A., Angioni, M. M., Follenzi, A., Quagliata, L., Ledda‐Columbano, G. M., Terracciano, L., et al. (2015) · Hepatology · doi:10.1002/hep.27790 · Cited by 88
Johnson, N. M., Egner, P. A., Baxter, V. K., Sporn, M. B., Wible, R. S., Sutter, T. R., Groopman, J. D., Kensler, T. W., & Roebuck, B. D. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0430 · Cited by 78 · cited 1×
“Indeed, in animal experiments, CDDO-Im substantially protects against aflatoxin B1-induced liver cancers [101].”
BackgroundGeneration of a New Model Rat:Nrf2 Knockout Rats Are Sensitive to Aflatoxin B1Toxicity
Taguchi, K., Takaku, M., Egner, P. A., Morita, M., Kaneko, T., Mashimo, T., Kensler, T. W., & Yamamoto, M. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw065 · Cited by 78
Self-citationFratta Pasini, A. M., Stranieri, C., Ferrari, M., Garbin, U., Cazzoletti, L., Mozzini, C., Spelta, F., Peserico, D., & Cominacini, L. (2020) · Respiratory Research · doi:10.1186/s12931-020-1292-7 · Cited by 74 · cited 2×
“In a longitudinal observational study, the GSH levels in plasma and the expression levels of NRF2-related genes in peripheral blood mononuclear cells appeared to serve as indicative biomarkers for the progression of disease in COPD patients [61,62].”
BackgroundNrf2 gene promoter polymorphism is associated with ulcerative colitis in a Japanese population.
Arisawa, T., Tahara, T., Shibata, T., Nagasaka, M., Nakamura, M., Kamiya, Y., Fujita, H., Yoshioka, D., Okubo, M., Sakata, M., et al. (2008) · PubMed · Cited by 71
Otsuki, A., Suzuki, M., Katsuoka, F., Tsuchida, K., Suda, H., Morita, M., Shimizu, R., & Yamamoto, M. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.12.005 · Cited by 70
Self-citationCórdova, E., Velázquez-Cruz, R., Centeno, F., Baca, V., & Orozco, L. (2010) · Lupus · doi:10.1177/0961203310367917 · Cited by 67 · cited 1×
“In fact, recent studies have demonstrated that single nucleotide polymorphisms (SNPs) in the human NRF2 promoter are associated with higher risks for the development of acute lung injury [45], ulcerative colitis [46], nephritis [47], vascular stiffness with aging [48] and cancers [49,50].”
BackgroundLiu, H., Zimmerman, A. W., Singh, K., Connors, S. L., Diggins, E., Stephenson, K. K., Dinkova-Kostova, A. T., & Fahey, J. W. (2020) · Scientific Reports · doi:10.1038/s41598-020-62714-4 · Cited by 65 · cited 1×
“In peripheral blood mononuclear cells from autism spectrum patients treated with orally delivered sulforaphane, the expression levels of the mRNAs for cytoprotective enzymes, including NQO1, HO-1, and AKR1C1, were increased; in contrast, the expression levels of proinflammatory cytokines, including IL6, IL1β, COX2 and…”
BackgroundMacLeod, A. K., Acosta-Jimenez, L., Coates, P. J., McMahon, M., Carey, F. A., Honda, T., Henderson, C. J., & Wolf, C. R. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.363 · Cited by 64 · cited 1×
“AKRs, including the AKR1B and AKR1C1/2/3 isozymes, at both the mRNA and protein levels were shown to be biomarkers for the diagnosis of NRF2-activated cancers in the lung [56].”
BackgroundNrf2 deficiency causes tooth decolourization due to iron transport disorder in enamel organ
Yanagawa, T., Itoh, K., Uwayama, J., Shibata, Y., Yamaguchi, A., Sano, T., Ishii, T., Yoshida, H., & Yamamoto, M. (2004) · Genes to Cells · doi:10.1111/j.1356-9597.2004.00753.x · Cited by 61
Self-citationThu, K. L., Pikor, L. A., Chari, R., Wilson, I. M., MacAulay, C. E., English, J. C., Tsao, M.-S., Gazdar, A. F., Lam, S., Lam, W. L., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182289479 · Cited by 60 · cited 1×
“For instance, the following proteins have been reported as candidates: mitochondrial serine/threonine protein phosphatase PGAM family member 5 (PGAM5) [38], NFκB kinase inhibitor IKKβ (inhibitor of nuclear factor-kappa B kinase subunit β, referred to as IKBKB) [39], BRCA2 partner PALB2 (partner and localizer of BRCA2)…”
BackgroundZhang, Y., Shi, Z., Zhou, Y., Xiao, Q., Wang, H., & Peng, Y. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01865 · Cited by 60 · cited 1×
“These proteins are reported to contain ETGE or ETGE-like motifs, which are required for binding to KEAP1 [42].”
BackgroundGeldanamycin-Derived HSP90 Inhibitors Are Synthetic Lethal with NRF2
Baird, L., Suzuki, T., Takahashi, Y., Hishinuma, E., Saigusa, D., & Yamamoto, M. P. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00377-20 · Cited by 59 · cited 1×
“A cell culture system was established in which KEAP1-deleted cells and KEAP1-expressing normal cells were cocultured, and their proliferation was monitored by the distinct colors of fluorescence [91].”
BackgroundSelf-citationMicroenvironmental Activation of Nrf2 Restricts the Progression of Nrf2-Activated Malignant Tumors
Hayashi, M., Kuga, A., Suzuki, M., Panda, H., Kitamura, H., Motohashi, H., & Yamamoto, M. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2888 · Cited by 56 · cited 2×
“To verify this notion, we exploited the KrasG12Ddriven lung adenocarcinoma system [96] and examined two mouse models with different NRF2 activity levels in the presence of adenovirus expressing Cre recombinase [97]: KEAP1flox-A mice [17] and KEAP1flox-B mice [98].”
BackgroundMethodSelf-citationImai, T. (1997) · Carcinogenesis · doi:10.1093/carcin/18.3.545 · Cited by 54
Lazzara, P. R., David, B. P., Ankireddy, A., Richardson, B. G., Dye, K., Ratia, K. M., Reddy, S. P., & Moore, T. W. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01074 · Cited by 51 · cited 1×
“The prototype 1,4-isoquinoline-based compound is hydrophilic and possesses negatively charged carboxylate groups that limit membrane permeability at physiological pH, but replacement of a carboxymethyl group with a fluoroalkyl group increases its metabolic stability, lipophilicity, and cellular activity (PRL-295) [95].”
BackgroundRichardson, B. G., Jain, A. D., Potteti, H. R., Lazzara, P. R., David, B. P., Tamatam, C. R., Choma, E., Skowron, K., Dye, K., Siddiqui, Z., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01133 · Cited by 51 · cited 1×
“Replacement of naphthalene with a 1,4-isoquinoline scaffold yields an improved mutagenic profile without reduced potency, stability or solubility [94].”
BackgroundYasuda, D., Nakajima, M., Yuasa, A., Obata, R., Takahashi, K., Ohe, T., Ichimura, Y., Komatsu, M., Yamamoto, M. P., Imamura, R. M., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.10.083 · Cited by 51 · cited 1×
“K67 is an NRF2 inhibitor that disturbs the PPI formed by KEAP1 and P62 phosphorylated at Ser349 in humans (S351 in mice) [89].”
BackgroundSelf-citationActivation of hepatic stellate cell in Pten null liver injury model
He, L., Gubbins, J., Peng, Z., Medina, V., Fei, F., Asahina, K., Wang, J., Kahn, M., Rountree, C. B., & Stiles, B. L. (2016) · Fibrogenesis & Tissue Repair · doi:10.1186/s13069-016-0045-1 · Cited by 49
Solt, D. B., Cayama, E., Sarma, D. S. R., & Farber, E. (1980) · PubMed · Cited by 49
Unoki, T., Akiyama, M., & Kumagai, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020545 · Cited by 46 · cited 1×
“Our personal environments, including lifestyle and food, drinking water, tobacco, alcohol and drug consumption, increase the risk of taking in toxic chemicals that produce oxidative and electrophilic stresses and damage macromolecules, such as nucleic acids, proteins and lipids [2].”
BackgroundBaird, L., & Yamamoto, M. P. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00473-20 · Cited by 44 · cited 2×
“In addition to these mutations, oncometabolites [70,71], exon skipping [72], and promoter methylation [73] lead to constitutive NRF2 activation in cancers [14,74].”
BackgroundSelf-citationPasini, A. M. F., Ferrari, M., Stranieri, C., Vallerio, P., Mozzini, C., Garbin, U., Zambon, G., & Cominacini, L. (2016) · International Journal of COPD · doi:10.2147/copd.s102218 · Cited by 43 · cited 2×
“In a longitudinal observational study, the GSH levels in plasma and the expression levels of NRF2-related genes in peripheral blood mononuclear cells appeared to serve as indicative biomarkers for the progression of disease in COPD patients [61,62].”
BackgroundYasuda, D., Ohe, T., Takahashi, K., Imamura, R. M., Kojima, H., Okabe, T., Ichimura, Y., Komatsu, M., Yamamoto, M. P., Nagano, T., et al. (2020) · Free Radical Research · doi:10.1080/10715762.2020.1732955 · Cited by 36 · cited 9×
“However, both P62- and KEAP1-positive lesions are detected in approximately 25% of human HCC and adjacent tissues.”
BackgroundInfluentialSelf-citationMacLeod, A. K., Acosta-Jimenez, L., Coates, P. J., McMahon, M., Carey, F. A., Honda, T., Hayes, J. D., Henderson, C. J., & Wolf, C. R. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.80 · Cited by 36
Tamberg, N., Tahk, S., Koit, S., Kristjuhan, K., Kasvandik, S., Kristjuhan, A., & Ilves, I. (2018) · Scientific Reports · doi:10.1038/s41598-018-30562-y · Cited by 35 · cited 1×
“For instance, the following proteins have been reported as candidates: mitochondrial serine/threonine protein phosphatase PGAM family member 5 (PGAM5) [38], NFκB kinase inhibitor IKKβ (inhibitor of nuclear factor-kappa B kinase subunit β, referred to as IKBKB) [39], BRCA2 partner PALB2 (partner and localizer of BRCA2)…”
BackgroundCho, H., Jedlicka, A., Gladwell, W., Marzec, J. M., McCaw, Z. R., Bienstock, R. J., & Kleeberger, S. R. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5942 · Cited by 32 · cited 1×
“Similarly, an rSNP is also found in the mouse NRF2 locus [52].”
BackgroundYamaguchi, Y., Kamai, T., Higashi, S., Murakami, S., Arai, K., Shirataki, H., & Yoshida, K. (2019) · BMC Cancer · doi:10.1186/s12885-019-6347-0 · Cited by 25 · cited 1×
“In fact, recent studies have demonstrated that single nucleotide polymorphisms (SNPs) in the human NRF2 promoter are associated with higher risks for the development of acute lung injury [45], ulcerative colitis [46], nephritis [47], vascular stiffness with aging [48] and cancers [49,50].”
BackgroundWDR23 regulates the expression of Nrf2-driven drug-metabolizing enzymes
Siswanto, F. M., Oguro, A., Arase, S., & Imaoka, S. (2020) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2020.06.007 · Cited by 21
Shimizu, S., Mimura, J., Hasegawa, T., Shimizu, E., Imoto, S., Tsushima, M., Kasai, S., Yamazaki, H., Ushida, Y., Suganuma, H., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236834 · Cited by 19 · cited 1×
“In fact, recent studies have demonstrated that single nucleotide polymorphisms (SNPs) in the human NRF2 promoter are associated with higher risks for the development of acute lung injury [45], ulcerative colitis [46], nephritis [47], vascular stiffness with aging [48] and cancers [49,50].”
BackgroundSelf-citationPetersen, D. R., Saba, L. M., Sayin, V. I., Papagiannakopoulos, T. Y., Schmidt, E. E., Merrill, G. F., Orlicky, D. J., & Shearn, C. T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198139 · Cited by 14 · cited 2×
“In Pten-Alb mice, p62 accumulation elevates the NRF2 level, at least partially, and NRF2 target genes are upregulated [78].”
BackgroundCellular Nrf2 Levels Determine Cell Fate during Chemical Carcinogenesis in Esophageal Epithelium
Horiuchi, M., Taguchi, K., Hirose, W., Tsuchida, K., Suzuki, M., Taniyama, Y., Kamei, T., & Yamamoto, M. P. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00536-20 · Cited by 13
Self-citationIs Carcinogenesis Fundamentally Adversarial–Confrontational or Physiologic–Adaptive?
Farber, E. (1993) · Journal of Investigative Dermatology · doi:10.1038/jid.1993.45 · Cited by 10
Cited by
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
Sies, H., Belousov, V. V., Chandel, N. S., Davies, M. J., Jones, D. P., Mann, G. E., Murphy, M. P., Yamamoto, M., & Winterbourn, C. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00456-z · Cited by 1,735
Self-citationNrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease
Ngo, V., & Duennwald, M. L. (2022) · Antioxidants · doi:10.3390/antiox11122345 · Cited by 1,130
Oxidative cell death in cancer: mechanisms and therapeutic opportunities
An, X., Yu, W., Liu, J., Tang, D., Yang, L., & Chen, X. (2024) · Cell Death & Disease · doi:10.1038/s41419-024-06939-5 · Cited by 523
“The role of NRF2 has been con fi rmed beyond initial assumptions, presenting both challenges and opportunities in cancer treatment [69].”
BackgroundMultifunctional nanoparticle-mediated combining therapy for human diseases
Li, X., Peng, X., Zoulikha, M., Boafo, G. F., Magar, K. T., Ju, Y., & He, W. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01668-1 · Cited by 521
“68 Tumorigenicity is regulated by two means of the Nrf2 antioxidant reply, either via Keap1-dependent and Keap1-independent mechanisms or via stimulating the development and cancer-cell survival, which are already inducted since Nrf2 and the anti-oxidative reply aids tumors in dealing with…”
BackgroundWang, Y., Cheng, H., Wang, T., Zhang, K., Zhang, Y., & Kang, X. (2023) · Cell Proliferation · doi:10.1111/cpr.13448 · Cited by 225
“release of Nrf2, which leads to the accumulation of Nrf2 in the cytoplasm and subsequent nuclear transfer.(104) After entering the nucleus,”
Background
Metadata
- Authors
- Taguchi, K., & Yamamoto, M.
- Affiliations
- Tohoku University (JP)
- Corresponding author
- Yamamoto, Masayuki
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2020-12-26
- Volume
- 13
- Issue
- 1
- Pages
- 46
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC7795874
- OpenAlex
- W3114836680
- Cited by
- 195
- References
- 115
- Citations by year
- 2026: 21 · 2025: 34 · 2024: 38 · 2023: 34 · 2022: 46 · 2021: 21
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology (19H05649, 19K07395)
- Core Research for Evolutional Science and Technology (16gm0410013h0006)
- Japan Agency for Medical Research and Development (JP20cm0106101)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- Keap1, Nrf2, Nrf2 inhibitors, Nrf2 inducers, oncogene addiction, tumor suppressor, oxidative stress response, metabolic reprogramming, tumor microenvironment, host immune cells, cancer therapy targets
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.